Konu "Biyobelirteç" için Tıbbi Laboratuvar Teknikleri Programı / Medical Laboratory Tecniques Program listeleme
Toplam kayıt 6, listelenen: 1-6
-
The importance of MicroRNA 106b as a biomarker in gastric cancer
(Japanese Journal of Gastroenterol Research, 2022)Objective: Gastric cancer (GC) is the fourth most common malignant disease worldwide, and it is observed 2-3 times more frequently in men than in women. It is important to make an early diagnosis in GC, by using screening ... -
The importance of MicroRNA 29a as a biomarker in colon cancer
(Genetics & Molecular Medicine, 2022)Introduction: Colon cancer (CC) has become one of the most common diseases in recent years.The incidence of (CC) varies greatly worldwide, depending on lifestyle, environment, and genetic causes. Endoscopy is invasive ... -
The importance of Microrna21 as biomarker in hepatocellular carcinoma
(Genetics & Molecular Medicine, 2022)Objective: Hepatocellular carcinoma (HCC) is the fifth most common cancer and the second leading cause of cancerrelated deaths worldwide.The diagnosis of HCC patients remains difficult, especially early in the development ... -
MicroRNAs as a biomarker in lung cancer
(Mattioli, 2023)Introduction: Lung cancer (LC) is the most common cancer in the world.Well known causes are long term smoking, environmental influences and genetic variations. LC is divided into two main types based on their histological ... -
The miR125b as biomarkers in the early diagnosis of bladder cancer
(Genetics & Molecular Medicine, 2022)Objective: Bladder cancer (BCa) is the fifth most common cancer and the second most common urinary tract cancer in worldwide. BCa accounts for 3% of all cancers and is particularly common in developed countries. Material ... -
Use of MicroRNAs as biomarkers in the early diagnosis of prostate cancer
Introduction: Prostate cancer (PCa) is a common type of cancer in western countries and prominent cause of mortality in men. The aim of the study was to evaluate miRNAs as biomarkers in PCa in healthy individuals and ...